Immune regulation by CD8 Treg cells: novel possibilities for anticancer immunotherapy.
作者信息
Zhang Shuping, Wu Meng, Wang Fang
机构信息
Department of Laboratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
出版信息
Cell Mol Immunol. 2018 Sep;15(9):805-807. doi: 10.1038/cmi.2018.170.
Abstract
摘要
相似文献
1
Immune regulation by CD8 Treg cells: novel possibilities for anticancer immunotherapy.CD8调节性T细胞的免疫调节作用：抗癌免疫疗法的新机遇
Cell Mol Immunol. 2018 Sep;15(9):805-807. doi: 10.1038/cmi.2018.170.
2
CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.CD8+调节性T细胞、其抑制机制及在癌症中的调节
Hum Immunol. 2008 Nov;69(11):811-4. doi: 10.1016/j.humimm.2008.08.276. Epub 2008 Sep 24.
3
OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function.OX40 激动剂肿瘤免疫疗法不会影响调节性 T 细胞的抑制功能。
J Immunol. 2019 Oct 1;203(7):2011-2019. doi: 10.4049/jimmunol.1900696. Epub 2019 Aug 21.
4
Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.卵巢癌患者CD8+调节性T细胞分析：免疫损伤的一种可能机制
Cell Mol Immunol. 2015 Sep;12(5):580-91. doi: 10.1038/cmi.2015.57. Epub 2015 Jul 13.
5
Regulatory T cells, tumour immunity and immunotherapy.调节性T细胞、肿瘤免疫与免疫疗法。
Nat Rev Immunol. 2006 Apr;6(4):295-307. doi: 10.1038/nri1806.
6
[The Role of Regulatory T-cells in Antitumor Immune Response].[调节性T细胞在抗肿瘤免疫反应中的作用]
Klin Onkol. 2015;28 Suppl 4:4S23-7. doi: 10.14735/amko20154s23.
7
Regulatory T cells in cancer immunotherapy.肿瘤免疫治疗中的调节性 T 细胞。
Curr Opin Immunol. 2014 Apr;27:1-7. doi: 10.1016/j.coi.2013.12.005. Epub 2014 Jan 14.
8
Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells.环磷酰胺抑制 CD8(+)调节性 T 细胞的生成和功能。
Hum Immunol. 2012 Mar;73(3):207-13. doi: 10.1016/j.humimm.2011.12.020. Epub 2012 Jan 14.
9
Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy.调节性 T 细胞靶向杂化纳米颗粒联合免疫检查点阻断用于癌症免疫治疗。
J Control Release. 2018 Jul 10;281:84-96. doi: 10.1016/j.jconrel.2018.05.018. Epub 2018 May 17.
10
Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8 T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.综合表达谱分析揭示了白细胞介素-33/ST2 轴与软组织肉瘤中 CD8 T 细胞、调节性 T 细胞和髓源抑制细胞的相关性。
Front Immunol. 2018 May 29;9:1179. doi: 10.3389/fimmu.2018.01179. eCollection 2018.
引用本文的文献
1
Recent advances in regulatory immune cells: exploring the world beyond Tregs.调节性免疫细胞的最新进展：探索Treg细胞之外的领域。
Front Immunol. 2025 May 16;16:1530301. doi: 10.3389/fimmu.2025.1530301. eCollection 2025.
2
Revolutionizing cancer treatment: the emerging potential and potential challenges of self-processed CAR cell therapy.变革癌症治疗：自体加工嵌合抗原受体（CAR）细胞疗法的新兴潜力与潜在挑战
Theranostics. 2024 Oct 28;14(19):7424-7447. doi: 10.7150/thno.101941. eCollection 2024.
3
Immune Checkpoints and Cellular Landscape of the Tumor Microenvironment in Non-Melanoma Skin Cancer (NMSC).非黑色素瘤皮肤癌（NMSC）中的肿瘤微环境免疫检查点和细胞景观。
Cells. 2024 Sep 26;13(19):1615. doi: 10.3390/cells13191615.
4
The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review.皮肤鳞状细胞癌的突变和微环境格局：综述
Cancers (Basel). 2024 Aug 21;16(16):2904. doi: 10.3390/cancers16162904.
5
Roles of exosomes in immunotherapy for solid cancers.外泌体在实体瘤免疫治疗中的作用。
Cell Death Dis. 2024 Feb 1;15(2):106. doi: 10.1038/s41419-024-06494-z.
6
The future of cancer immunotherapy: DNA vaccines leading the way.癌症免疫疗法的未来：DNA 疫苗引领潮流。
Med Oncol. 2023 Jun 9;40(7):200. doi: 10.1007/s12032-023-02060-3.
7
Circulating CD4 Treg, CD8 Treg, and CD3 γδ T Cell Subpopulations in Ovarian Cancer.卵巢癌患者外周血 CD4+Treg、CD8+Treg 和 CD3γδT 细胞亚群的变化。
Medicina (Kaunas). 2023 Jan 20;59(2):205. doi: 10.3390/medicina59020205.
8
Understanding the squamous cell carcinoma immune microenvironment.理解鳞状细胞癌的免疫微环境。
Front Immunol. 2023 Jan 30;14:1084873. doi: 10.3389/fimmu.2023.1084873. eCollection 2023.
9
Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy.卵巢癌肿瘤免疫微环境的代谢重编程：免疫治疗的新方向。
Front Immunol. 2022 Oct 14;13:1030831. doi: 10.3389/fimmu.2022.1030831. eCollection 2022.
10
FoxP3 CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation.急性 HIV 感染及早期抗逆转录病毒治疗启动后 FoxP3+CD8+T 细胞。
Front Immunol. 2022 Jul 29;13:962912. doi: 10.3389/fimmu.2022.962912. eCollection 2022.
本文引用的文献
1
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.癌症中调节性T细胞的代谢调控：免疫治疗的机遇
Trends Cancer. 2017 Aug;3(8):583-592. doi: 10.1016/j.trecan.2017.06.005. Epub 2017 Jul 14.
2
Regulatory T cells in cancer immunotherapy.癌症免疫治疗中的调节性T细胞。
Cell Res. 2017 Jan;27(1):109-118. doi: 10.1038/cr.2016.151. Epub 2016 Dec 20.
3
Gene expression profiling of CD8 T cells induced by ovarian cancer cells suggests a possible mechanism for CD8 Treg cell production.卵巢癌细胞诱导的CD8 T细胞基因表达谱分析提示了CD8调节性T细胞产生的一种可能机制。
Cell Prolif. 2016 Dec;49(6):669-677. doi: 10.1111/cpr.12294. Epub 2016 Sep 19.
4
TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment.转化生长因子-β1通过p38丝裂原活化蛋白激酶信号通路在卵巢癌微环境中促进CD8+调节性T细胞的诱导。
Oncotarget. 2016 Jul 12;7(28):44534-44544. doi: 10.18632/oncotarget.10003.
5
Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.卵巢癌患者CD8+调节性T细胞分析：免疫损伤的一种可能机制
Cell Mol Immunol. 2015 Sep;12(5):580-91. doi: 10.1038/cmi.2015.57. Epub 2015 Jul 13.
6
Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β.调节性 T 细胞与变应性疾病的免疫调控：IL-10 和 TGF-β的作用。
Genes Immun. 2014 Dec;15(8):511-20. doi: 10.1038/gene.2014.45. Epub 2014 Jul 24.
7
Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.接受手术的非小细胞肺癌患者中CD4+CD25+FOXP3+和CD8+CD28-调节性T细胞的变化。
Int Immunopharmacol. 2014 Feb;18(2):255-61. doi: 10.1016/j.intimp.2013.12.004. Epub 2013 Dec 15.
8
CD11c(high)CD8+ regulatory T cell feedback inhibits CD4 T cell immune response via Fas ligand-Fas pathway.CD11c(高)CD8+ 调节性 T 细胞反馈通过 Fas 配体-Fas 途径抑制 CD4 T 细胞免疫反应。
J Immunol. 2013 Jun 15;190(12):6145-54. doi: 10.4049/jimmunol.1300060. Epub 2013 May 15.
9
Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal.索拉非尼通过抑制 TGF-β 信号减少肝癌患者肝内浸润的调节性 T 细胞。
J Surg Oncol. 2013 Mar;107(4):422-7. doi: 10.1002/jso.23227. Epub 2012 Jul 25.
10
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.在结直肠癌组织中鉴定CD8+CD25+Foxp3+抑制性T细胞。
Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.
Zotero 插件